Verseon Corp is a California-based company that is revolutionizing drug development through the use of physics and artificial intelligence. With their proprietary technology platform, they engineer novel drugs atom by atom, offering treatments for major human diseases that cannot be found through any other method.
Verseon's first-in-class drug candidates aim to change the standard of care for various diseases, including preventing heart attacks and strokes with lower bleeding risk, treating diabetic vision loss without eye injections, providing chemo agents for multidrug-resistant cancers, preventing aggressive solid-tumor cancer metastasis, and restoring immune response to CD73 positive cancers. Their innovative approach holds the promise of improving the lives of millions of patients worldwide.
Generated from the website